These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7587070)

  • 1. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
    Hupp TR; Lane DP
    Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.
    Takenaka I; Morin F; Seizinger BR; Kley N
    J Biol Chem; 1995 Mar; 270(10):5405-11. PubMed ID: 7534296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the cryptic DNA binding function of mutant forms of p53.
    Hupp TR; Meek DW; Midgley CA; Lane DP
    Nucleic Acids Res; 1993 Jul; 21(14):3167-74. PubMed ID: 8341590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric activation of latent p53 tetramers.
    Hupp TR; Lane DP
    Curr Biol; 1994 Oct; 4(10):865-75. PubMed ID: 7850419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.
    Hupp TR; Lane DP
    J Biol Chem; 1995 Jul; 270(30):18165-74. PubMed ID: 7629129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events.
    Subramanian D; Griffith JD
    Biochemistry; 2005 Feb; 44(7):2536-44. PubMed ID: 15709766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
    Prowald A; Schuster N; Montenarh M
    FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
    Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
    J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small peptides activate the latent sequence-specific DNA binding function of p53.
    Hupp TR; Sparks A; Lane DP
    Cell; 1995 Oct; 83(2):237-45. PubMed ID: 7585941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15.
    Dumaz N; Milne DM; Meek DW
    FEBS Lett; 1999 Dec; 463(3):312-6. PubMed ID: 10606744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.
    Milne DM; McKendrick L; Jardine LJ; Deacon E; Lord JM; Meek DW
    Oncogene; 1996 Jul; 13(1):205-11. PubMed ID: 8700548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of casein kinase II with immunopurified p53.
    Herrmann CP; Kraiss S; Montenarh M
    Oncogene; 1991 May; 6(5):877-84. PubMed ID: 2052362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
    McKendrick L; Milne D; Meek D
    Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
    Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
    Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
    Blaydes JP; Hupp TR
    Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.